Alamar Biosciences, Inc. - 10-Q Filing

Alamar Biosciences reports Q3 2025 financial results including details on SVB loan agreements and convertible debt obligations.

SEC EDGAR ·

Tickers: $ALMR

Read the full article at SEC EDGAR

More Regulatory news